Market Overview
Global diagnostic market for influenza is growing at a CAGR of 7.8 percent over the forecast period. Market growth is mainly driven by factors such as rising influenza occurrence, growth in research funding for influenza diagnosis, and increasing demand for faster diagnosis are the major factors expected to drive this market’s growth in the coming years. High-risk influenza populations consist of pregnant women, infants, the elderly, immunosuppressed patients suffering from chronic medical conditions, and health care staff.
Influenza Diagnostics Market: Segments
In 2019 the traditional diagnostic segment dominated the market, in test type. RIDT section held the largest share of the influenza diagnostic market’s for traditional diagnostic tests.
The large proportion of this section can be attributed to the rising adoption of cost-effective and faster RIDT as the first line of diagnosis and screening phase has been increased among end-users. These tests are antigen detection assays that detects influenza viral antigens within 10 to 15 minutes with high specificity. Rapid influenza diagnostic tests can identify the presence of influenza A and B viral antigens in respiratory samples and exhibit the result in a qualitative way. This test are antigen detection assays which detect highly specific viral antigens of influenza within 10 to 15 minutes. It is a significant factor responsible for the largest share of the RIDT demand.
For Any Query: https://www.wiseguyreports.com/sample-request/5686927-influenza-diagnostics-market-outlook-2030-industry-insights-opportunity
Influenza Diagnostics Market: Drivers and Restraints
Drivers
Rising Population and Government Initiatives
Growing geriatric population, rising government anti-influenza measures, increasing prevalence of chronic diseases such as diabetes, heart and blood disorders, and the emergence of technologically advanced influenza diagnostic tests are some of the key factors driving growth in the market for influenza diagnostics. Geriatric population is vulnerable to a wide variety of diseases because they are immunologically poor to combat illness and are also at significant risk of influenza contracting.
Restraints
Lack of Awareness and Healthcare Infrastructure
Most people in underdeveloped countries and remote areas are unaware of the symptoms of this disease or lack adequate healthcare facilities and equipment or infrastructure, making it difficult to even diagnose the disease within a short timespan, as well as increasing prices of kits and reagents used for influenza diagnosis may hinder the growth of the market. The existence of a complicated regulatory framework to approve new diagnostic tests and increasing healthcare costs are expected to restrict this market’s growth to some degree in the coming years.
The Influenza Diagnostics Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Influenza Diagnostics Market: Key Players
- Abbott Laboratories (Include Alere)
o Company Overview
o Business Strategy
o Key Product Offerings
o Financial Performance
o Key Performance Indicators
o Risk Analysis
o Recent Development
o Regional Presence
o SWOT Analysis
- Siemens Healthineers
- Analytik Jena
- Quidel Corporation
- Genome Diagnostics
- Meridian Bioscience
- BioMerieux SA
- Sekisui Diagnostics
- Response Biomedical
- SA Scientific
- Enigma Diagnostics
- Focus Diagnostics
- Other Prominent Players
For Any Query: https://www.wiseguyreports.com/enquiry/5686927-influenza-diagnostics-market-outlook-2030-industry-insights-opportunity
The Influenza Diagnostics Market report also contains analysis on:
- Influenza Diagnostics Market Segments:
By Test Type
- Traditional Diagnostic Tests
o RIDT
o Viral Culture
o DFA
o Serological assays
- Molecular Diagnostic Tests
o RT-PCR
o INNAT
TMA
LAMP
NASBA
Other INNAT
o Other Molecular Tests
By End-User
- Hospitals
- Clinical Laboratories
- Research Centers
- Point of Care Testing Centers.
- Other End-User
By Type of Flu
- Type A Flu
- Type B Flu
- Type C Flu
- Influenza Diagnostics Market Dynamics
- Influenza Diagnostics Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Table of Contents
- Executive Summary
- Influenza Diagnostics
- Research Methodology
- Average Pricing Analysis
- Market Dynamics
- Recent Development, Policies& Regulatory Landscape
- Risk Analysis
- Influenza DiagnosticsIndustry Analysis
- Global Influenza Diagnostics Market
- Global Influenza Diagnostics Market: Market Segmentation
- Company Profile
Read Other Reports from our Database :
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Contact Us:
Ph: +162 825 80070 (US)
Ph: +44 203 500 2763 (UK)
